Patents Assigned to Merk Sharp & Dohme Ltd.
  • Patent number: 7094777
    Abstract: Compounds of formula I: are antagonists of the human 5-HT2A receptor, and hence useful in treatment or prevention of a variety of neurological conditions.
    Type: Grant
    Filed: November 9, 2004
    Date of Patent: August 22, 2006
    Assignee: Merk Sharp & Dohme Ltd.
    Inventors: Mark Stuart Chambers, Neil Roy Curtis, Angus Murray MacLeod, Robert James Maxey, Helen Jane Szekeres